Study of Imetelstat in Patients with Low or Intermediate Risk Myelodysplastic Syndromes (MDS) Refractory to Erythropoiesis-Stimulating Agents
- Substances:Imetelstat Sodium
Germany- Participants:18–64 years · 65+ years
- Substances:Imetelstat Sodium
Rare diseases
Investigational molecules
Locations
GermanyStudy on the Effects of Guselkumab and Golimumab for Patients with Moderate to Severe Ulcerative Colitis
GermanyStudy of Chemoradiotherapy With or Without Pembrolizumab for Patients With High-Risk, Locally Advanced Cervical Cancer
GermanyStudy on the Safety and Effectiveness of Ripasudil Eye Drops for Patients with Fuchs Endothelial Corneal Dystrophy After Descemetorhexis
GermanyStudy Comparing Inclisiran and Bempedoic Acid for Lowering LDL Cholesterol in Patients with Atherosclerotic Cardiovascular Disease
GermanyStudy of Encorafenib, Binimetinib, and Pembrolizumab for Patients with Advanced Melanoma with BRAF V600E/K Mutation
GermanyStudy on the Effects of Dexamethasone in Patients with Aneurysmal Subarachnoid Hemorrhage
GermanyStudy on Tiotropium for Preventing Severe Asthma Attacks in Preschool Children with Uncontrolled Asthma
GermanyStudy of pirtobrutinib, venetoclax and rituximab combination compared to venetoclax and rituximab in previously treated Chronic Lymphocytic Leukemia patients
GermanyStudy on the Effectiveness and Safety of Budesonide and Formoterol Fumarate for Patients with Poorly Controlled Asthma
GermanyStudy on the Effectiveness and Safety of Ralinepag for Patients with Pulmonary Arterial Hypertension
GermanyStudy of ExPEC9V vaccine for preventing invasive E.
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.